Evidence map›Paper›PMID 41173947›Full record

ArticleScientific reports2025

Toxic effects of biodegradable polylactic acid nanoplastics on developing zebrafish (Danio rerio).

F Scalia, F Capparucci, M D Amico, M Marino, E P Lamparelli, L Longhitano, S Giallongo, R Falleti, F Rappa, C Iaria and 7 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

F Scalia *Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127, Palermo, Italy.
F Capparucci *Institute Slavko Bambir, Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166, Messina, Italy.
M D AmicoDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127, Palermo, Italy.
M MarinoDepartment of Medicine, Surgery and Dentistry, University of Salerno, 84081, Baronissi, Italy.
E P LamparelliDepartment of Medicine, Surgery and Dentistry, University of Salerno, 84081, Baronissi, Italy.
L LonghitanoDepartment of Biomedical and Biotecnological Sciences (BIOMETEC), University of Catania, 95100, Catania, Italy.
S GiallongoDepartment of Medicine and Surgery, University Kore of Enna, 94100, Enna, Italy.
R FalletiInstitute Slavko Bambir, Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166, Messina, Italy.
F RappaDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127, Palermo, Italy.
C IariaInstitute Slavko Bambir, Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166, Messina, Italy.
F MarinoInstitute Slavko Bambir, Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98166, Messina, Italy.
G Della PortaDepartment of Medicine, Surgery and Dentistry, University of Salerno, 84081, Baronissi, Italy.
A Marino GammazzaDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, 90128, Palermo, Italy.
F BucchieriDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127, Palermo, Italy.
A SantoroDepartment of Medicine, Surgery and Dentistry, University of Salerno, 84081, Baronissi, Italy.
F CappelloDepartment of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127, Palermo, Italy.
M A SzychlinskaDepartment of Precision Medicine in Medical, Surgical and Critical Care (MEPRECC), University of Palermo, Via del Vespro N. 129, 90127, Palermo, Italy. martaanna.szychlinska@unipa.it.

Funding

European Union - Next Generation EU" M4C2 component, investment 1.1, "Fund for the National Research Program and Projects of Significant National Interest (PRIN) PRIN-PNRR2022: P2022AA47Y_003
6 · The paper itself

Abstract

Plastic contamination represents a significant threat to the environment with potential health risks for all species. Recently, bio-based plastics have been introduced as a green alternative to fossil-based ones. However, bioplastic degradation products present potentially harmful effects comparable to the fossil-based ones. Polylactic acid (PLA) is one of the most widely used bioplastics in the world and it requires high temperatures found in industrial composting, to degrade fully. These conditions are not typical of natural environments, where PLA degradation leads to the accumulation of micro- and nanoplastics. According to this finding, the aim of the present study was to assess PLA nanoplastics (PLA-NPs) potential harmful biological effects. PLA-NPs exposure effects have been assessed through the in vivo study on early-stage zebrafish bioaccumulation, cellular stress induction, and morpho-physiology, and through the in vitro study on HDF, used to mimic one of the modes of contamination route in humans, to evaluate their cellular uptake potential. For this purpose, zebrafish embryos were exposed to fluorescent PLA-NPs at the concentrations of 0.1 and 1 mg/L, up to 5 days. In the study, the parallel experiments were conducted by exposing zebrafish embryos to polystyrene MPs (PS-MPs), used as a well-established harmful positive control. No alterations in the Zebrafish Embryo Acute Toxicity Test parameters were found; however, heartbeat rate alteration in the PLA-NPs-treated zebrafish at 96 and 120 hpf have been observed. No remarkable morphological alterations of brain and liver tissue have been detected. The bioaccumulation of PLA-NPs was detectable at 72 and 96 hpf, presumably in the gastrointestinal tract. The gene expression analysis of cellular stress markers (hmox1, nos2, sod1, sod2, il1β, tnfα, il4, il13, infγ, tbx21) showed inflammation and oxidative stress induction in zebrafish at 72 and 120 hpf. Finally, HDF demonstrated uptake potential, suggesting their ability to bypass the dermal human barrier. The obtained results, accompanied by those on the exposure of developing zebrafish, and HDF cells, to the same concentrations of PS-MPs, raise concerns about the biological impact of PLA-based bioplastics and their use as a safe alternative to petroleum-based plastics.

Indexed as

Biodegradable PlasticsMicroplasticsNanoparticlesPolyestersZebrafishAnimalsEmbryo, NonmammalianBiodegradable PlasticsMicroplasticsPolyesterspoly(lactide)Developmental toxicityHuman dermal fibroblastsPolylactic acid nanoplasticsPolystyrene microplasticsZebrafish

Identifiers

PMID41173947
PMCPMC12578981

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.